For instance, SETD1A, a histone H3K4 methyltransferase, has been shown to transcriptionally activate YAP1, thereby promoting primary resistance to sorafenib in hepatocellular carcinoma.100. Here, YAP1 is linked to hepatocellular carcinoma.